This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elezi, S. Articles by Kastrati, A. Search for Related Content PubMed PubMed Citation Articles by Elezi, S. Articles by Kastrati, A.

Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease

Shpend Elezi, MD^_*, Alban Dibra, MD^_*, Ulrike Folkerts, MD^_*, Julinda Mehilli, MD^_*, Sylvia Heigl, Albert Schömig, MD and Adnan Kastrati, MD^_*,_*

^_* Deutsches Herzzentrum
1. Medizinische Klinik rechts der Isar, Technische Universität; Munich, Germany

View larger version (25K): [in a new window]   Figure 1 Initial hospital costs and follow-up costs for the patients who underwent implantation of sirolimus-eluting and paclitaxel-eluting stents. p < 0.001 for the difference between the 2 drug-eluting stents with respect to follow-up costs.